Lower risk Drug recall · FDA · Published July 23, 2026

Aurobindo Pharma recalls 10mg Dicyclomine Capsules due to empty capsules

Aurobindo Pharma USA recalls 10mg Dicyclomine Hydrochloride Capsules (1,000 bottles) after reports of empty capsules. This prescription drug was distributed by Aurobindo Pharma USA, Inc. in New Jersey.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0733-2026Drug Aurobindo Pharma ›

Lower-risk recall

shortfill; reports of empty capsules.

✎ GovInfoNow plain-language explainer

Aurobindo Pharma USA is recalling 1,000 bottles of 10mg Dicyclomine Hydrochloride Capsules (Rx only) because some capsules have been reported as empty. This could mean the medication is not working as intended for people taking it. Read more at govinfonow.com/recall/309273-aurobindo-pharma-recalls-10mg-dicyclomine-capsules-due-to-empty-capsules.

Source Summary by GovInfoNow · govinfonow.com/recall/309273-aurobindo-pharma-recalls-10mg-dicyclomine-capsules-due-to-empty-capsules · Updated August 18, 2026 · FDA enforcement record: FDA #D-0733-2026

Cite this page

“Aurobindo Pharma recalls 10mg Dicyclomine Capsules due to empty capsules.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/309273-aurobindo-pharma-recalls-10mg-dicyclomine-capsules-due-to-empty-capsules. Based on FDA recall #D-0733-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0733-2026%22&limit=1).

The FDA announced on July 23, 2026, that Aurobindo Pharma USA Inc is recalling Dicyclomine Hydrochloride Capsules due to shortfill and reports of empty capsules. The agency issued recall number D-0733-2026 for the Class II voluntary recall.

How to tell if you have it

Brand: Aurobindo Pharma
Product: Dicyclomine Hydrochloride Capsules, USP, 10mg
NDC: 59651-719-99
Batch #: DMC125018A
Exp Date: 07/2027
Quantity: 1,000 bottles per unit; 6,408 total bottles distributed

The hazard

The recall addresses shortfill issues and reports of empty capsules within the product. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Aurobindo Pharma USA Inc has 32 other recalls on record since April 9, 2013. In May 2025, the company recalled Acetaminophen Tablets due to brown tablet discoloration risk caused by cGMP deviations. Other recent recalls of similar products include ANI Pharmaceuticals Estradiol Gel (May 12, 2026), Asclemed Duloxetine Capsules (May 14, 2026), and Golden State Medical Prasugrel HCl Tablets (August 21, 2026).

How to tell if you have this one

Check for the product name 'Dicyclomine Hydrochloride Capsules, USP, 10mg' on the label. The product was distributed by Aurobindo Pharma USA, Inc. in New Jersey and has a batch number starting with DMC125018A.

Brand
Aurobindo Pharma
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Capsule Contents
If the capsules appear empty, stop using them and contact your doctor.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

Jul 23, 2026Firm started the recall
Aug 4, 2026FDA classified it Class II
Aug 12, 2026Published in FDA’s Enforcement Report
Aug 18, 2026Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/309273-aurobindo-pharma-recalls-10mg-dicyclomine-capsules-due-to-empty-capsules">Aurobindo Pharma recalls 10mg Dicyclomine Capsules due to empty capsules (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0733-2026 (July 23, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0733-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.